JP2005512016A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005512016A5 JP2005512016A5 JP2002561950A JP2002561950A JP2005512016A5 JP 2005512016 A5 JP2005512016 A5 JP 2005512016A5 JP 2002561950 A JP2002561950 A JP 2002561950A JP 2002561950 A JP2002561950 A JP 2002561950A JP 2005512016 A5 JP2005512016 A5 JP 2005512016A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- partial sequence
- peptide
- hla
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 56
- 108090000765 processed proteins & peptides Proteins 0.000 claims 29
- 150000001413 amino acids Chemical class 0.000 claims 22
- 102000025850 HLA-A2 Antigen Human genes 0.000 claims 13
- 108010074032 HLA-A2 Antigen Proteins 0.000 claims 13
- 239000000427 antigen Substances 0.000 claims 13
- 108091007433 antigens Proteins 0.000 claims 13
- 102000036639 antigens Human genes 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 108700028369 Alleles Proteins 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 2
- 230000005867 T cell response Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26496901P | 2001-01-29 | 2001-01-29 | |
| US09/935,476 US20040096445A1 (en) | 1999-06-30 | 2001-08-22 | Subunit vaccines with A2 supermotifs |
| PCT/US2002/002708 WO2002061435A2 (en) | 2001-01-29 | 2002-01-29 | Subunit vaccines with a2 supermotifs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005512016A JP2005512016A (ja) | 2005-04-28 |
| JP2005512016A5 true JP2005512016A5 (enExample) | 2006-01-05 |
Family
ID=26950859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002561950A Pending JP2005512016A (ja) | 2001-01-29 | 2002-01-29 | Ａ２スーパーモチーフを有するサブユニットワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040096445A1 (enExample) |
| EP (1) | EP1368659A2 (enExample) |
| JP (1) | JP2005512016A (enExample) |
| KR (1) | KR20040052475A (enExample) |
| CN (1) | CN1653337A (enExample) |
| AU (1) | AU2002243730B2 (enExample) |
| CA (1) | CA2432995C (enExample) |
| CZ (1) | CZ20032054A3 (enExample) |
| IL (1) | IL156660A0 (enExample) |
| MX (1) | MXPA03006581A (enExample) |
| NZ (1) | NZ526860A (enExample) |
| RU (1) | RU2003126447A (enExample) |
| SK (1) | SK9512003A3 (enExample) |
| WO (1) | WO2002061435A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7611713B2 (en) * | 1993-03-05 | 2009-11-03 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide compositions |
| US20110097352A9 (en) * | 1992-01-29 | 2011-04-28 | Pharmexa Inc. | Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
| EP1078092B1 (en) * | 1998-05-13 | 2011-08-03 | Epimmune Inc. | Expression vectors for stimulating an immune response and methods of using the same |
| JP2003509465A (ja) * | 1999-07-19 | 2003-03-11 | エピミューン， インコーポレイテッド | ペプチドおよび核酸組成物を使用する、ｃ型肝炎ウイルスに対する細胞性免疫応答の誘導 |
| US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
| US7462354B2 (en) * | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
| US20040248113A1 (en) * | 1999-12-28 | 2004-12-09 | Alessandro Sette | Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| WO2005012502A2 (en) * | 2003-03-28 | 2005-02-10 | Idm Pharma, Inc. | Methods of identifying optimal variants of peptide epitopes |
| EP2391635B1 (en) | 2009-01-28 | 2017-04-26 | Epimmune Inc. | Pan-dr binding polypeptides and uses thereof |
| CN110214275B (zh) * | 2016-12-01 | 2022-12-06 | 南托米克斯有限责任公司 | 肿瘤抗原性加工和呈递 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2370413A1 (en) * | 1999-06-29 | 2001-01-04 | Epimmune Inc. | Hla binding peptides and their uses |
| AU2605501A (en) * | 1999-12-21 | 2001-07-03 | Epimmune, Inc. | Inducing cellular immune responses to prostate cancer antigens using peptide andnucleic acid compositions |
-
2001
- 2001-08-22 US US09/935,476 patent/US20040096445A1/en not_active Abandoned
-
2002
- 2002-01-29 IL IL15666002A patent/IL156660A0/xx unknown
- 2002-01-29 SK SK951-2003A patent/SK9512003A3/sk not_active Application Discontinuation
- 2002-01-29 AU AU2002243730A patent/AU2002243730B2/en not_active Ceased
- 2002-01-29 CN CNA028042484A patent/CN1653337A/zh active Pending
- 2002-01-29 MX MXPA03006581A patent/MXPA03006581A/es not_active Application Discontinuation
- 2002-01-29 NZ NZ526860A patent/NZ526860A/en unknown
- 2002-01-29 CA CA2432995A patent/CA2432995C/en not_active Expired - Fee Related
- 2002-01-29 JP JP2002561950A patent/JP2005512016A/ja active Pending
- 2002-01-29 WO PCT/US2002/002708 patent/WO2002061435A2/en not_active Ceased
- 2002-01-29 EP EP02709233A patent/EP1368659A2/en not_active Withdrawn
- 2002-01-29 KR KR10-2003-7010024A patent/KR20040052475A/ko not_active Ceased
- 2002-01-29 CZ CZ20032054A patent/CZ20032054A3/cs unknown
- 2002-01-29 RU RU2003126447/15A patent/RU2003126447A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005514030A5 (enExample) | ||
| JP2005512016A5 (enExample) | ||
| JP2004512815A5 (enExample) | ||
| EP2343318A3 (en) | Antibodies binding to a C-terminal fragment of apolipoprotein E | |
| WO2009051555A3 (en) | Modified mhc class i binding peptides | |
| JP2018526970A5 (enExample) | ||
| EP2287201A3 (en) | RS7 antibodies | |
| JP2011505800A5 (enExample) | ||
| EP2330129A3 (en) | Anti-TNF antibodies, compositions, methods and uses | |
| JP2017501728A5 (enExample) | ||
| EP1741782A9 (en) | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof | |
| JP2002524024A5 (enExample) | ||
| CY1113153T1 (el) | ΙL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ | |
| WO2008076255A3 (en) | Canine thymic stromal lymphopoietin protein and uses thereof | |
| JP2007525465A5 (enExample) | ||
| IL273648B1 (en) | Microbiota sequence variants of tumor-related antigenic epitopes | |
| JP2012516140A5 (enExample) | ||
| WO2005010023A3 (en) | Method for prediction of an epitope | |
| WO2003018797A3 (en) | Method and device for integrated protein expression, purification and detection | |
| RU2003126447A (ru) | Вакцины на основе субъединиц с супермотивами а2 | |
| JP2006522210A5 (enExample) | ||
| JP2006503088A5 (enExample) | ||
| JP2001516567A5 (enExample) | ||
| ATE451618T1 (de) | Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika | |
| WO2000035484A3 (en) | Methods and compositions for decreasing allergic reactions to surface allergens |